Exact Mass: 512.110727
Exact Mass Matches: 512.110727
Found 156 metabolites which its exact mass value is equals to given mass value 512.110727,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Temocapril hydrochloride
C23H29ClN2O5S2 (512.1206334000001)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
{2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-6-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl}oxidanesulfonic acid
{2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl}oxidanesulfonic acid
3-(4-Hydroxy-3-methoxyphenyl)-1,2-propanediol 2-O-(galloyl-glucoside)
3-(4-Hydroxy-3-methoxyphenyl)-1,2-propanediol 2-O-(galloyl-glucoside) is found in herbs and spices. 3-(4-Hydroxy-3-methoxyphenyl)-1,2-propanediol 2-O-(galloyl-glucoside) is a constituent of the fruit of allspice (Pimenta dioica) Constituent of the fruit of allspice (Pimenta dioica). 3-(4-Hydroxy-3-methoxyphenyl)-1,2-propanediol 2-O-(galloyl-glucoside) is found in herbs and spices.
Picrosid II, HPLC Grade
Dehydrophthalocyanine
D011838 - Radiation-Sensitizing Agents
I-Bop
Kutkoside
(2S)-2-[[4-[(2,4-Diaminopteridin-6-yl)methyl]-2,3-dihydro-1,4-benzothiazine-7-carbonyl]amino]hexanedioic acid
Ampicoside
Picroside II is a natural product found in Veronica pulvinaris, Veronica thomsonii, and other organisms with data available. Picroside II, an iridoid compound extracted from Picrorhiza, exhibits anti-inflammatory and anti-apoptotic activities. picroside II alleviates the inflammatory response in sepsis and enhances immune function by inhibiting the activation of NLRP3 inflammasome and NF-κB pathways[1]. Picroside II is an antioxidant, exhibits a significant neuroprotective effect through reducing ROS production and protects the blood-brain barrier (BBB) after cerebral ischemia-reperfusion (CI/R) injury. Picroside II has antioxidant, anti-inflammatory, immune regulatory, anti-virus and other pharmacological activities[2]. Picroside II, an iridoid compound extracted from Picrorhiza, exhibits anti-inflammatory and anti-apoptotic activities. picroside II alleviates the inflammatory response in sepsis and enhances immune function by inhibiting the activation of NLRP3 inflammasome and NF-κB pathways[1]. Picroside II is an antioxidant, exhibits a significant neuroprotective effect through reducing ROS production and protects the blood-brain barrier (BBB) after cerebral ischemia-reperfusion (CI/R) injury. Picroside II has antioxidant, anti-inflammatory, immune regulatory, anti-virus and other pharmacological activities[2].
Picroside
Picroside II is a natural product found in Veronica pulvinaris, Veronica thomsonii, and other organisms with data available. Picroside II, an iridoid compound extracted from Picrorhiza, exhibits anti-inflammatory and anti-apoptotic activities. picroside II alleviates the inflammatory response in sepsis and enhances immune function by inhibiting the activation of NLRP3 inflammasome and NF-κB pathways[1]. Picroside II is an antioxidant, exhibits a significant neuroprotective effect through reducing ROS production and protects the blood-brain barrier (BBB) after cerebral ischemia-reperfusion (CI/R) injury. Picroside II has antioxidant, anti-inflammatory, immune regulatory, anti-virus and other pharmacological activities[2]. Picroside II, an iridoid compound extracted from Picrorhiza, exhibits anti-inflammatory and anti-apoptotic activities. picroside II alleviates the inflammatory response in sepsis and enhances immune function by inhibiting the activation of NLRP3 inflammasome and NF-κB pathways[1]. Picroside II is an antioxidant, exhibits a significant neuroprotective effect through reducing ROS production and protects the blood-brain barrier (BBB) after cerebral ischemia-reperfusion (CI/R) injury. Picroside II has antioxidant, anti-inflammatory, immune regulatory, anti-virus and other pharmacological activities[2].
Picroside II
Picroside II, an iridoid compound extracted from Picrorhiza, exhibits anti-inflammatory and anti-apoptotic activities. picroside II alleviates the inflammatory response in sepsis and enhances immune function by inhibiting the activation of NLRP3 inflammasome and NF-κB pathways[1]. Picroside II is an antioxidant, exhibits a significant neuroprotective effect through reducing ROS production and protects the blood-brain barrier (BBB) after cerebral ischemia-reperfusion (CI/R) injury. Picroside II has antioxidant, anti-inflammatory, immune regulatory, anti-virus and other pharmacological activities[2]. Picroside II, an iridoid compound extracted from Picrorhiza, exhibits anti-inflammatory and anti-apoptotic activities. picroside II alleviates the inflammatory response in sepsis and enhances immune function by inhibiting the activation of NLRP3 inflammasome and NF-κB pathways[1]. Picroside II is an antioxidant, exhibits a significant neuroprotective effect through reducing ROS production and protects the blood-brain barrier (BBB) after cerebral ischemia-reperfusion (CI/R) injury. Picroside II has antioxidant, anti-inflammatory, immune regulatory, anti-virus and other pharmacological activities[2].
3,5,7-Trihydroxyflavone 3-glucoside-8-sulfate
Tuberculatin
Diphyllin apioside is a natural product found in Justicia patentiflora, Garcinia subelliptica, and other organisms with data available.
apigenin 7-beta-D-glucopyranosyl-2-sulfate|thalassiolin C
Di-Me ester-3,4-Dihydro-6-hydroxy-2-[5-hydroxy-4-carboxynaphtho[1,2-b]furan-2-yl]-2-methyl-2H-naphtho[1,2-b]pyran-5-carboxylic acid
1-O-galloyl-6-O-(4-hydroxy-3,5-dimethoxy)benzoyl-beta-D-glucose|1-O-galloyl-6-O-(4-hydroxy-3,5-dimethoxybenzoyl)-beta-D-glucose
1-(3,4-dimethoxy-5-hydroxyphenyl)-6-(3,5-dimethoxygalloyl)-beta-D-glucopyranose|1-O-3,4-dimethoxy-5-hydroxyphenyl-6-O-(3,5-di-O-methylgalloyl)-beta-glucopyranoside|3,4-dimethoxy-5-hydroxyphenyl 6-O-(3,5-di-O-methylgalloyl)-beta-D-glucopyranoside
4-hydroxy-2,6-dimethoxyphenyl 6-O-syringoyl-beta-D-glucopyranoside
(+/-)-(1beta,2alpha,3beta,4alpha)-1,2-di-(2,4-dihydroxybenzoyl)-3,4-di-(4-hydroxyphenyl)cyclobutane|Dimeric 4,2,4-trihydroxydihydrochalcone
(-)-tuberculatin|(?)-4-[(D-apio-beta-D-furanosyl)oxy]-9-(1,3-benzodioxol-5-yl)-6,7-dimethoxy-1H-naphtho[2,3-c]furan-3-one|diphyllin apioside|diphyllin-1-O-beta-D-apiofuranoside|tuberculatin
7-<6-(4-O-acetyl-alpha-L-rhamnopyranosyloxy)-beta-D-glucopyranosyloxy>coumarin|7-[6-(4-O-acetyl-alpha-L-rhamnopyranosyloxy)-beta-D-glucopyranosyloxy]coumarin
3-methoxyumbilicaric acid|3-Methoxyumilicaric acid
Peracetate Quercetin
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.197 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.201
C23H28O13_(1aS,1bS,2S,5aR,6S,6aS)-2-(beta-D-Glucopyranosyloxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-6-yl 4-hydroxy-3-methoxybenzoate
N6-Aristololactam-II-deoxyadenosine
C26H20N6O6 (512.1444260000001)
Cys Asp Glu Phe
C21H28N4O9S (512.1576918000001)
Cys Asp Phe Glu
C21H28N4O9S (512.1576918000001)
Cys Glu Asp Phe
C21H28N4O9S (512.1576918000001)
Cys Glu Phe Asp
C21H28N4O9S (512.1576918000001)
Cys Glu Met Met
Cys Phe Asp Glu
C21H28N4O9S (512.1576918000001)
Cys Phe Glu Asp
C21H28N4O9S (512.1576918000001)
Cys Met Glu Met
Cys Met Met Glu
Asp Cys Glu Phe
C21H28N4O9S (512.1576918000001)
Asp Cys Phe Glu
C21H28N4O9S (512.1576918000001)
Asp Glu Cys Phe
C21H28N4O9S (512.1576918000001)
Asp Glu Phe Cys
C21H28N4O9S (512.1576918000001)
Asp Phe Cys Glu
C21H28N4O9S (512.1576918000001)
Asp Phe Glu Cys
C21H28N4O9S (512.1576918000001)
Glu Cys Asp Phe
C21H28N4O9S (512.1576918000001)
Glu Cys Phe Asp
C21H28N4O9S (512.1576918000001)
Glu Cys Met Met
Glu Asp Cys Phe
C21H28N4O9S (512.1576918000001)
Glu Asp Phe Cys
C21H28N4O9S (512.1576918000001)
Glu Phe Cys Asp
C21H28N4O9S (512.1576918000001)
Glu Phe Asp Cys
C21H28N4O9S (512.1576918000001)
Glu Met Cys Met
Glu Met Met Cys
Phe Cys Asp Glu
C21H28N4O9S (512.1576918000001)
Phe Cys Glu Asp
C21H28N4O9S (512.1576918000001)
Phe Asp Cys Glu
C21H28N4O9S (512.1576918000001)
Phe Asp Glu Cys
C21H28N4O9S (512.1576918000001)
Phe Glu Cys Asp
C21H28N4O9S (512.1576918000001)
Phe Glu Asp Cys
C21H28N4O9S (512.1576918000001)
Met Cys Glu Met
Met Cys Met Glu
Met Glu Cys Met
Met Glu Met Cys
Met Met Cys Glu
Met Met Glu Cys
I-Bop
3-(4-Hydroxy-3-methoxyphenyl)-1,2-propanediol 2-O-(galloyl-glucoside)
BMS-777607
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
3,3-diethyl-2,2-oxathiacarbocyanine iodide
C25H25IN2O2 (512.0960699999999)
9,10-Anthracenedione,2,2-(1,3,4-oxadiazole-2,5-diyl)bis[1-amino-
C30H16N4O5 (512.1120645999999)
2-CHLORO-N-(2-(PYRIDIN-3-YLAMINO)PYRIMIDIN-5-YL)-5-(3-(TRIFLUOROMETHYL)BENZAMIDO)BENZAMIDE
BIS(3-ISOPROPYL-4-METHOXYPHENYL)IODONIUM TETRAFLUOROBORATE
2,2-methylenebis[6-(o-isocyanatobenzyl)phenyl] diisocyanate
2-amino-6-(4-chlorophenyl)sulfanyl-4-[1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]pyridine-3,5-dicarbonitrile
[(2R,5R)-3-acetyloxy-5-[[5-cyano-6-(4-methylphenyl)sulfanylpyridine-3-carbonyl]carbamoylamino]oxolan-2-yl]methyl acetate
Trovafloxacin Mesylate
C21H19F3N4O6S (512.0977350000001)
A methanesulfonate (mesylate) salt prepared from equimolar amounts of trovafloxacin and methanesulfonic acid. A broad-spectrum antibiotic that was withdrawn from the market due to risk of liver failure. D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
1-O-3,4-dimethoxy-5-hydroxyphenyl-(6-O-3,5-dimethoxygalloyl)-beta-D-glucopyranoside
A beta-D-glucoside compound having 4,5-dimethoxybenzene-1,3-diol as the anomeric and 4-hydroxy-3,5-dimethoxybenzoic acid as the substituent at position 6. It has been isolated from the stems of Gordonia chrysandra and exhibits inhibitory effect on nitric oxide production.
Benzoic acid, 3,5-dichloro-2,4-dihydroxy-6-pentyl-, 4-carboxy-3-methoxy-5-pentylphenyl ester
5-O-{[(1S)-1-carboxylatoethoxy]phosphinato}-1-deoxy-1-(8-hydroxy-2,4-dioxo-2H-pyrimido[4,5-b]quinolin-3-id-10(4H)-yl)-D-ribitol
(E)-7-[3-[(E)-3-hydroxy-4-(4-iodophenoxy)but-1-enyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid
N-[4-[[3-(4-sulfamoylanilino)-2-quinoxalinyl]sulfamoyl]phenyl]acetamide
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-2-[(4-ethyl-5-phenyl-1,2,4-triazol-3-yl)thio]acetamide
N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-5-methyl-N-(thiophen-2-ylmethyl)-2,1,3-benzothiadiazole-4-sulfonamide
2-(1,3-dimethyl-2,6-dioxo-7-purinyl)-N-[3-[(4-methoxyphenyl)sulfamoyl]-4-methylphenyl]acetamide
(4-{(E)-[5-(4-chlorophenyl)-6-(ethoxycarbonyl)-7-methyl-3-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-2(3H)-ylidene]methyl}phenoxy)acetic acid
ustilaginoidin A(2-)
A phenolate anion that is the conjugate base of ustilaginoidin A, obtained by deprotonation of the two hydroxy groups at positions 5 and 5. It is the major microspecies at pH 7.3.
bPiDDB
bPiDDB is a potent nAChR antagonist. bPiDDB potently (IC50=2 nM) inhibits nicotine-evoked striatal dopamine (DA) release through an interaction with α6β2-containing nAChRs[1].
GSK-25
GSK-25 is a potent, selective and orally bioavailable ROCK1 inhibitor (IC50=7 nM). GSK-25 maintains good selectivity against a panel of 31 kinases (>100 fold), as well as RSK1 and p70S6K (RSK1: IC50=398 nM, p70S6K: IC50=1 μM). GSK-25 inhibits P450 profile (IC50s of 2.5, 5.2, 2.5 μM for CYP2C9, CYP2D6, CYP3A4, respectively)[1].
PLX7904
C24H22F2N6O3S (512.1442086000001)
PLX7904 is a potent and selective BRAF inhibitor, with IC50 of appr 5 nM against BRAFV600E in mutant RAS expressing cells.
(2s,3s)-7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-9,12-dimethoxy-2,3-dihydro-1,4,5-trioxatetraphen-10-one
(1r,3s,4s,7r,8s,12s,13s)-3,4,7-trihydroxy-13-(2-hydroxy-3,4-dimethoxyphenyl)-17-methyl-9-oxa-14,15-dithia-10,17-diazatetracyclo[10.3.2.0¹,¹⁰.0³,⁸]heptadec-5-ene-11,16-dione
C21H24N2O9S2 (512.0923174000001)
methyl (1's,9'r)-3',5',11',13'-tetrahydroxy-9'-(4-hydroxyphenyl)-4,8'-dioxospiro[cyclohexane-1,16'-tetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁵]hexadecan]-2,2',4',5,6',10',12',14'-octaene-1'-carboxylate
15-(acetyloxy)-6-chloro-9-hydroxy-2,11,15-trimethyl-7-methylidene-3,14-dioxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadec-12-en-17-yl 2-hydroxyacetate
11,24-dihydroxy-7,9,20,22-tetramethyl-8,16,21,30-tetraoxaoctacyclo[15.11.1.1⁴,²⁸.0²,¹⁵.0³,¹².0⁵,¹⁰.0¹⁸,²³.0²⁵,²⁹]triaconta-1,3,5(10),11,14,17(29),18(23),24,27-nonaene-13,26-dione
(17s,18s)-18-[(2s)-4-(2,6-dihydroxyphenyl)-4-oxobutan-2-yl]-3,11,15-trihydroxy-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2,4,6,9,11,14,16(20)-octaen-13-one
(6s,9's)-1,1',4',5',6,9-hexahydroxy-2',6-dimethyl-5,7-dihydro-9'h-[2,9'-bianthracene]-8,10'-dione
(1r,3s,4r,7r,8s,12s,13r)-3,4,7-trihydroxy-13-(2-hydroxy-3,4-dimethoxyphenyl)-17-methyl-9-oxa-14,15-dithia-10,17-diazatetracyclo[10.3.2.0¹,¹⁰.0³,⁸]heptadec-5-ene-11,16-dione
C21H24N2O9S2 (512.0923174000001)
23-(2,6-dihydroxyphenyl)-4,6,14-trihydroxy-18,20-dimethyl-9-oxapentacyclo[17.3.1.0⁵,²².0⁸,²¹.0¹⁰,¹⁵]tricosa-1(23),3,5,7,10,12,14,21-octaene-2,16-dione
2-(hydroxymethyl)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 3-hydroxy-4-methoxybenzoate
methyl (2s)-6-hydroxy-2-[5-hydroxy-4-(methoxycarbonyl)naphtho[1,2-b]furan-2-yl]-2-methyl-3h,4h-naphtho[1,2-b]pyran-5-carboxylate
(1r,6s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxy-3-methoxybenzoate
2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxy-3-methoxybenzoate
3-[(2s,3s)-3-(2,4-dihydroxybenzoyl)-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-5-yl]-1-(2,4-dihydroxyphenyl)propan-1-one
[(1s,2s,4s,5s,6r,10s)-5-hydroxy-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-2-yl]methyl 4-hydroxy-3-methoxybenzoate
methyl 3',5',11',13'-tetrahydroxy-9'-(4-hydroxyphenyl)-4,8'-dioxospiro[cyclohexane-1,16'-tetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁵]hexadecan]-2,2',4',5,6',10',12',14'-octaene-1'-carboxylate
(1r,3s,4r,7r,8s,12s,13s)-3,4,7-trihydroxy-13-(2-hydroxy-3,4-dimethoxyphenyl)-17-methyl-9-oxa-14,15-dithia-10,17-diazatetracyclo[10.3.2.0¹,¹⁰.0³,⁸]heptadec-5-ene-11,16-dione
C21H24N2O9S2 (512.0923174000001)